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PLINICAL RESEARCH Acute Coronary Syndromes
ender and Myocardial Salvage After
eperfusion Treatment in Acute Myocardial Infarction
ulinda Mehilli, MD,* Gjin Ndrepepa, MD,* Adnan Kastrati, MD,* Stephan G. Nekolla, PHD,‡
hristina Markwardt, MD,* Hildegard Bollwein, MD,† Jürgen Pache, MD,* Stefan Martinoff, MD,*
osef Dirschinger, MD,† Markus Schwaiger, MD,‡ Albert Schömig, MD†
unich, Germany
OBJECTIVES The aim of this study was to investigate whether there are gender-associated differences in the
amount of myocardial salvage after primary percutaneous coronary intervention (PCI) in
patients with acute myocardial infarction (AMI).
BACKGROUND Despite having a more adverse cardiovascular risk profile, women with AMI have similar or
even better outcomes after primary PCI compared with men. The reasons for these findings
are unclear.
METHODS In this study we included 202 women and 561 men with AMI who underwent primary PCI
in the setting of three randomized trials. The primary end point of the study was myocardial
salvage index (proportion of initial perfusion defect salvaged by reperfusion therapy), obtained
by paired scintigraphic studies performed 7 to 10 days apart.
RESULTS The amount of myocardium at risk or initial perfusion defect (median [25th, 75th
percentiles]) did not differ significantly between women and men (22.0% [12.0, 40.0] vs.
24.0% [14.0, 39.0] of the left ventricle [LV], p  0.26). Final infarct size, measured in the
follow-up scintigraphy, was significantly smaller in women than in men (6.0% [0.71, 18.7] vs.
10.0% [3.9, 21.8] of the LV, p  0.001). Myocardial salvage index was 0.64 (0.35, 0.95) in
women versus 0.50 (0.26, 0.77) in men (p  0.001). After adjustment for baseline
characteristics, female gender was an independent predictor of greater myocardial salvage after
PCI (p  0.002).
CONCLUSIONS The efficacy of primary PCI in patients with AMI appears to be gender-dependent.
Myocardial salvage achieved by primary PCI is greater in women than in men. (J Am Coll
ublished by Elsevier Inc. doi:10.1016/j.jacc.2004.11.054Cardiol 2005;45:828–31) © 2005 by the American College of Cardiology Foundation
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pespite the fact that women, by the time of acute myocar-
ial infarction (AMI), are older and have a more adverse
ardiovascular risk profile, studies investigating the influ-
nce of gender on the outcome after primary percutaneous
oronary intervention (PCI) have reported no differences in
he short- or long-term mortality between the genders (1,2).
n a recent study that included more than 2,000 patients
ith AMI treated mostly with primary PCI, we demon-
trated similar short- and long-term prognosis in both
enders; however, after adjustment for age, female gender
as associated with a 35% reduction in mortality (2). To
ate, no studies have addressed whether there are gender-
elated differences in the amount of jeopardized myocar-
ium that is salvaged by mechanical reperfusion in patients
ith AMI. Therefore, we undertook this study to assess the
mpact of gender on the myocardial salvage achieved by
rimary PCI with adjunct antiplatelet therapy in patients
ith AMI.
From the *Deutsches Herzzentrum; †1. Medizinische Klinik rechts der Isar; and
he ‡Nuklearmedizinische Klinik rechts der Isar, Technischen Universität, Munich,
ermany.o
Manuscript received October 1, 2004; revised manuscript received November 16,
004, accepted November 22, 2004.ETHODS
atients and study protocol. We included in this study
63 patients with AMI within the first 48 hours of symptom
nset receiving primary PCI as reperfusion therapy between
ecember 1997 and February 2002, in the setting of three
andomized trials: Stent Versus Thrombolysis for Occluded
oronary Arteries in Patients with Acute Myocardial In-
arction (STOPAMI)-1 and -2, and Stent or Percutaneous
ransluminal Coronary Angioplasty for Occluded Coronary
rteries in Patients with Acute Myocardial Infarction
neligible for Thrombolysis (STOPAMI)-3 trial (3–5). In
he STOPAMI-1 and -2 trials, patients with AMI eligible
or thrombolysis were randomized to receive coronary stent-
ng plus abciximab (152 patients), or thrombolysis applied
s alteplase alone (69 patients) or as half-dose alteplase plus
bciximab (81 patients) (3,4). In the STOPAMI-3 trial,
atients with AMI ineligible for thrombolysis were ran-
omly assigned to undergo coronary stenting (305 patients)
r plain balloon angioplasty (306 patients) (5). All included
atients provided written informed consent for participating
n the three trials.
Detailed information about patient enrollment and study
esigns has been previously published (3–5). Shortly, all
atients received 500 mg of aspirin and a bolus of 60 U/kg
f heparin intravenously. In addition, they received an
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March 15, 2005:828–31 Gender and Myocardial Salvagentravenous injection of 27 mCi of 99mtechnetium (Tc)-
estamibi required for the baseline scintigraphic study. In
atients without contraindications, abciximab was used as
djunct therapy. Post-interventional oral antiplatelet ther-
py consisted of ticlopidine, given at a dose of 250 mg twice
aily, or clopidogrel, given at a dose 75 mg daily, for four
eeks, and aspirin given at a dose of 100 mg twice a day
ndefinitely. Qualitative and quantitative assessment of dig-
tal angiograms was performed off-line using the automated
dge detection system CMS (Medis Medical Imaging
ystems, Nuenen, the Netherlands) in the Angiographic
ore Laboratory. Classification of anterograde coronary
ow in the infarct-related artery was done according to
Table 1. Patients’ Demographics, Cardiovascul
W
(n
Age (yrs) 72.9
Arterial hypertension 158
Diabetes 50
On insulin therapy 15
Current smoker 51
Cholesterol level (mg/dl) 200
Prior myocardial infarction 21
Prior CABG 4
Prior PTCA 6
Anterior myocardial infarction 88
Pre-infarct angina 98
Killip class
1 132
2 44
3 12
4 14
Time to admission (h) 10.3
Time door-to-balloon (h) 1.58
Initial perfusion detect, % of the LV*
Therapy at discharge
22.0
Statins 170
Beta-blocker 182
ACE inhibitors 176
Data are presented as number (percentage) or median [25th
Abbreviations and Acronyms
AMI  acute myocardial infarction
LV  left ventricle
PCI  percutaneous coronary intervention
SPECT  single-photon emission computed
tomography
STOPAMI  Stent Versus Thrombolysis for
Occluded Coronary Arteries in Patients
With Acute Myocardial Infarction trial
STOPAMI-3  Stent or Percutaneous Transluminal
Coronary Angioplasty for Occluded
Coronary Arteries in Patients With
Acute Myocardial Infarction Ineligible
for Thrombolysis trial
Tc  technetium
TIMI  Thrombolysis In Myocardial InfarctionACE  angiotensin-converting enzyme; CABG  aortocoro
percutaneous transluminal coronary angioplasty.hrombolysis In Myocardial Infarction (TIMI) classifica-
ion (6). Collateral circulation was quantified according to
entrop et al. (7). Post-discharge clinical follow-up con-
isted of telephone interviews at one month and a hospital
isit at six months after the initial procedure.
9mTc-sestamibi scintigraphy. The first scintigraphy
as performed within six to eight hours after injection of
7 mCi (1,000 MBq) of 99mTc-sestamibi. A follow-up
cintigraphy was scheduled 7 to 10 days after intervention.
aired scintigraphic examinations were used to calculate
hree parameters: initial perfusion defect and final infarct
ize, both expressed as a percentage of the left ventricle
LV), as well as myocardial salvage, calculated as initial
erfusion defect minus final infarct size divided by initial
erfusion defect. The measurement of scintigraphic
mages was performed off-line in the scintigraphic core
aboratory by operators unaware of patients’ treatment and
haracteristics.
Of the 763 patients receiving primary PCI in the
TOPAMI trials, 634 (83.0%) had technically satisfactory
aired 99mTc-sestamibi scintigraphic studies needed for
etermination of salvage index. No gender-dependent dif-
erence in the rate of completed paired scintigraphic studies
as observed (161 women, 80.0% vs. 473 men, 84.3%, p 
.14). The primary end point of the study was the salvage
ndex.
tatistical analysis. The data are presented as median
25th, 75th percentiles) or as counts or proportions. The
ifferences between women and men were assessed with
sk Profile, and Infarct Characteristics
en
02)
Men
(n  561)
p
value
, 87.6] 60.0 [51.5, 80.3] 0.001
) 358 (63.8) 0.001
) 109 (19.4) 0.11
20 (3.6) 0.08
) 249 (44.4) 0.001
240] 199 [170, 234] 0.12
) 89 (15.9) 0.06
24 (4.3) 0.14
56 (10.7) 0.04
) 238 (42.6) 0.78
) 224 (40.0) 0.03
0.14
) 396 (70.6) —
) 109 (19.4) —
15 (2.7) —
41 (7.3) —
40.9] 8.0 [2.4, 37.1] 0.004
2.0] 1.59 [1.3, 1.9] 0.52
, 40.0] 24.0 [14.0, 39.0] 0.26
) 489 (87.7) 0.27
) 515 (92.3) 0.56
) 500 (89.7) 0.54
percentiles]. *Available in 161 women and 473 men.ar Ri
om
 2
[60.7
(78.2
(24.8
(7.4)
(25.2
[173,
(10.4
(2.0)
(7.6)
(44.0
(49.0
(65.4
(21.8
(5.9)
(6.9)
[4.4,
[1.3,
[12.0
(84.7
(91.1
(88.1
, 75th
nary bypass graft surgery; LV  left ventricle; PTCA 
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Gender and Myocardial Salvage March 15, 2005:828–31wo-sided chi-square test for categorical data or nonpara-
etric Wilcoxon rank sum test for continuous data. Differ-
nces in clinical outcome data between women and men
ere assessed by the use of Mantel-Haenszel analysis with
tratification by STOPAMI trial. Multiple linear regression
nalysis was used to assess the independent impact of gender
n myocardial salvage while adjusting for other variables.
he following parameters were entered into the model: age,
iabetes, arterial hypertension, cholesterol level, smoking,
revious myocardial infarction, previous coronary angio-
lasty, previous coronary bypass graft surgery, Killip class,
nterior infarction, time-to-admission interval, initial coro-
ary TIMI flow grade, and pre-infarct angina. A two-tailed
 0.05 was considered to indicate statistical significance.
ESULTS
f the 763 patients receiving primary PCI as reperfusion
herapy in the STOPAMI-1, -2, and -3 trials, 202 (26.0%)
ere women and 561 (74.0%) were men. Patient character-
stics are shown in Table 1. Women were older, had arterial
ypertension and pre-infarct angina more often, and pre-
able 2. Patients’ Angiographic and Procedural Characteristics
Women
(n  202)
Men
(n  561)
p
value
ultivessel disease 129 (63.9) 363 (64.7) 0.83
nfarct-related coronary
artery
0.21
LAD 89 (44.0) 242 (43.1) —
LCX 48 (23.8) 112 (20.0) —
RCA 62 (30.7) 183 (32.6) —
Bypass graft 3 (1.5) 24 (4.3) —
nitial TIMI flow grade 0.25
0 113 (55.9) 324 (57.8) —
1 13 (6.5) 51 (9.1) —
2 38 (18.8) 110 (19.6) —
3 38 (18.8) 76 (13.5) —
ollateral distribution
grade
0.43
0 118 (58.4) 313 (55.8) —
1 54 (26.7) 164 (29.2) —
2 24 (11.9) 76 (13.6) —
3 6 (3.0) 8 (1.4) —
essel size (mm) 2.79 [2.5, 3.1] 3.0 [2.7, 3.4] 0.001
nitial minimal lumen
diameter (mm)
0 [0, 0.5] 0 [0, 0.5] 0.52
alloon-to-vessel ratio 1.07 [1.0, 1.1] 1.05 [1.0, 1.1] 0.29
inal minimal lumen
diameter (mm)
2.5 [2.1, 2.9] 2.7 [2.3, 3.1] 0.001
oronary stenting 123 (61.0) 334 (60.0) 0.74
bciximab 188 (93.1) 516 (92.0) 0.62
inal TIMI flow grade 0.67
0 4 (2.0) 13 (2.2) —
1 4 (2.0) 7 (1.3) —
2 11 (5.5) 42 (7.5) —
3 183 (90.5) 499 (89.0) —
ata are presented as number (percentage) or median [25th, 75th percentiles].
LAD  left anterior descending coronary artery; RCA  right coronary artery;
CX  left circumflex coronary artery; TIMI  Thrombolysis In Myocardial
nfarction.ented later in the hospital after symptom onset as compared go men. Furthermore, there was a trend for a higher
ncidence of diabetes in women than in men.
With the exception of vessel size and final minimal lumen
iameter, no other significant differences were observed
etween the genders with regard to the angiographic or
rocedural characteristics (Table 2).
ender and myocardial salvage. Initial perfusion defect or
yocardium at risk did not differ significantly between
omen and men (22.0% [12.0, 40.0] vs. 24.0% [14.0, 39.0]
f the LV, p  0.26). Final infarct size was significantly
maller in women than in men (6.0% [0.71, 18.7] vs. 10.0%
3.9, 21.8] of the LV, p  0.001). Salvage index was 0.64
0.35, 0.95) in women versus 0.50 (0.26, 0.77) in men (p 
.001) (Fig. 1). This advantage of female gender regarding
alvage index remained even when subgroups of patients
ith first AMI (0.69 [0.37, 0.96] in women vs. 0.52 [0.27,
.8] in men, p 0.001) or patients eligible for thrombolysis
0.70 [0.49, 0.91] in women vs. 0.52 [0.31, 0.69] in men, p
0.005) were analyzed separately. In the subgroup of
atients with pre-infarct angina, women had a trend for
igher salvage index (0.71 [0.32, 0.97]) than men (0.57
0.29, 0.83], p 0.08). After adjustment in the multivariate
odel, female gender (p  0.002) and pre-infarct angina (p
0.03) were identified as independent factors associated
ith a higher salvage index. A higher Killip class at
resentation (p  0.001), a longer symptom onset-to-
dmission interval (p  0.01), and a history of previous
yocardial infarction (p  0.02) were independently asso-
iated with a lower salvage index.
linical outcome at six months. Six female and 15 male
atients experienced recurrent myocardial infarction (3.0%
s. 2.7%, respectively; p  0.82). Stroke occurred in five
omen and in two men (2.5% vs. 0.4%, respectively; p 
.02). Eighteen women and 42 men died within this period
8.9% vs. 7.5%, respectively; p  0.64). Nonstroke-related
ortality was 6.9% in women (n  14) and 7.3% in men (n
41), p  0.97. Twelve women (5.9%) and 37 men (6.6%)
ied of cardiac causes (p  0.74).
ISCUSSION
his study demonstrates for the first time a significant
igure 1. Median (25th, 75th percentiles) of salvage index according to
ender.ender difference in the degree of myocardial salvage after
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March 15, 2005:828–31 Gender and Myocardial Salvageechanical reperfusion in AMI, with women having a
reater amount of myocardium at risk salvaged than men.
he degree of anterograde coronary flow before and after
eperfusion and the presence of coronary collateral vessels,
hich have been proposed as predictors of the degree of
yocardial salvage by reperfusion (8,9), were not different
etween the genders in our study and thus cannot explain
he observed differences.
In the present study, more than 90% of the patients
eceived aggressive antiplatelet therapy with abciximab as an
djunct to PCI. Platelets of women have been demonstrated
o show a greater sensitivity to aggregating stimuli (10,11).
hus, women may benefit to a greater degree from effective
ntiplatelet inhibition by abciximab. Women presenting
ith AMI in our study reported pre-infarction angina more
requently than men. Pre-infarct angina may have protective
ffects leading to limitation of the infarct size, a greater
yocardial viability upon reperfusion, and an improvement
n the long-term survival and left ventricular function
12,13). Ischemic pre-conditioning and enhancement of
pontaneous thrombolysis due to adenosine-related platelet
ggregation inhibition during angina, leading to an increase
n the hypoxic tolerance of the myocardial tissue, have been
uggested as underlying explanative mechanisms. Experi-
ental studies have provided evidence that the hypoxic
olerance and its underlying mechanisms are gender-specific
14,15). Female cells present a higher basal expression of the
urvival-associated protein Bcl-2, showing a higher inher-
ted hypoxic tolerance than male cells. Moreover, upon
re-conditioning, female cells—because of a significant
ower activation of signaling pathways that control cell
poptosis—develop a higher tolerance to induced hypoxia
han do male cells (16). Another factor possibly playing a
ole with respect to the increase in hypoxic tolerance seems
o be the activation of estrogen receptor in cardiac cells upon
re-conditioning. Because of more functional and a higher
ensity of estrogen receptors, even low blood levels of
strogen may confer resistance to female, but not male,
ardiomyocytes against intracellular Ca2 loading induced
y hypoxia-reoxygenation (15).
These gender-related differences in the hypoxia tolerance
ay result in a better local myocardial response to ischemic
njury in women and may explain the greater myocardial
alvage in women than in men.
In conclusion, women with acute myocardial infarction
reated with mechanical reperfusion and adjunct platelet
lycoprotein IIb/IIIa receptor inhibitors show a higher
egree of myocardial salvage than men. This may improve
he chances of survival of women, despite their more adverse
ardiovascular profile.eprint requests and correspondence: Dr. Julinda Mehilli, Deut-
ches Herzzentrum, Lazarettstr. 36, 80636 München, Germany.
-mail: mehilli@dhm.mhn.de.
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